Topic guide
Articles and reference material connected to this topic, organised for clear reading.
Reading path
(Delayed Data from NSDQ) $13.20 USD 13.20 180,676 -0.28 (-2.08%) Updated Aug 21, 2026 04:00 PM ET After-Market: $13.25 +0.05 (0.38%) 7:58 PM ET This is our short term rating system that serves as a timeliness …
Read guide →The information on TargetWatch is for general information purposes only. TargetWatch makes no guarantees of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availabil…
Read guide →You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various in…
Read guide →ONCO Onconetix Inc Price Momentum ONCO is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of ONCO shares has decreased $0.02 since the market la…
Read guide →Compare with Oncopeptides AB Market capitalization 664.72 M SEK — — −0.845 SEK −249.59 M SEK 71.12 M SEK 295.87 M Beta (1Y) −0.18 Next report date — Report period — EPS estimate — Revenue estimate — …
Read guide →For patients with few options, innovation offers hope At Oncopeptides, we are dedicated to turning research into therapies that change lives. This is how we do it. Our Science We are innovative and curious, an…
Read guide →Portfolios Equity sectors Symbols Symbols Trend Change Price Change % Change Prev Close Open High Low Volume Mkt Cap SIXB Materials SIXB Materials SIXB +2.10% — 1,135.71 +2.10% 1,135.71 +23.36 +2.10% 1,112.35 …
Read guide →Wall St Price Targets Wall Street analysts forecast ONCO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ONCO is 2.516 SEK with a low forecas…
Read guide →Reported Estimate Reported Estimate Disclaimer This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms …
Read guide →Stockholm – April 28, 2026 – Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that the 2025 Annual Report has been published. “2025 was …
Read guide →Close: 1.68 (-0.07), Aug 21, 2026 See Recommendation Automatic technical analysis. Medium term, Aug 21, 2026 Investors have accepted lower prices over time to get out of Oncopeptides and the stock is in a fall…
Read guide →